Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs

Author(s):  Harrington Catherine A, Cauffield Jacintha

Issue:  May/Jun 2005 - Veterinary Compounding
View All Articles in Issue

Page(s):  201-205

Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs Page 1
Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs Page 2
Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs Page 3
Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs Page 4
Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs Page 5

Download in electronic PDF format for $65

Abstract:  Selection of the “best” antihypertensive therapy was an issue of great debate among clinicians in the past. As large meta-analytic studies have shown, all antihypertensive drugs lower blood pressure by about the same amount; the main differences are in their side effects, cost, and frequency of administration. The side effect profiles, along with the patient’s comorbid conditions, should determine the combination of drugs to use. For the most part, side effects from antihypertensive drugs are predictable since they are dose related. When hypertension coexists with other cardiac conditions, drugs that treat both hypertension and other conditions at the same time should be chosen. Physicians should be encouraged to aggressively pursue treatment goals in hypertension, and meta-analysis has shown that combination drug therapy is the best way to reduce doses and side effects while maintaining effectiveness in blood pressure control. Compounded combinations let physicians tailor prescriptions to the patient; individualizing the mix of drugs and doses allows more aggressive treatment while controlling side effects and cost of therapy.

Related Keywords: Catherine A. Harrington, PharmD, PhD, Jacintha Cauffield, PharmD, BCPS, hypertension, high blood pressure, antihypertensive medication, combination drug regimens, adverse effects, side effects, drug costs

Related Categories: BUSINESS, CARDIOLOGY

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs
Harrington Catherine A
, Cauffield Jacintha
May/Jun 2005
Pg. 201-205

Veterinary Transdermal Medications: A to Z
Davidson Gigi S
Mar/Apr 2003
Pg. 106-113

Combating Cardiovascular Disease With Compounded Medications. Part 1: Combination Cardiac Medicines to Control Blood Pressure
Harrington Catherine A
, Cauffield Jacintha
Mar/Apr 2005
Pg. 117-119

Novel Approaches to Topical Psoriasis Therapy
Koyama Gregory
, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
Sep/Oct 2015
Pg. 357-365

Pain: Systematic Review of Pharmacy Compounding of Pain Medication
Shawaqfeh Mohammad S
, Harrington Catherine
Jan/Feb 2018
Pg. 19-24

Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Beshay Sarah M
, Rivera Gerard, Balthasar Jan, Florea Naomi
Jul/Aug 2015
Pg. 295-300

Incorporating Quality Assurance in Pharmaceutical Compounding-related Courses in the PharmD Curricula
Hossain Mohammad Faisal
, Levesque Dan, Frye John, Rashid Mamoon
Jul/Aug 2020
Pg. 322-326

The Role of Compounding Pharmacists During Drug Shortages
Ofei Kelvin
Jul/Aug 2022
Pg. 298-301

The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women
Stephenson Kenna
, Neuenschwander Pierre F, Kurdowska Anna K
Jan/Feb 2013
Pg. 74-85

View Sample
Pharmacogenomics: Precision Pharmacy in 503A Compounding
Drummond Joseph
, Bennet Daron, Allen Loyd V Jr
Mar/Apr 2018
Pg. 95-107